INVESTOR ALERT REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Tetraphase Pharmaceutical...
August 13 2018 - 1:32PM
Business Wire
The Schall Law Firm, a national shareholder rights litigation
firm, announces the filing of a class action lawsuit against
Tetraphase Pharmaceuticals, Inc. (“Tetraphase” or “the Company”)
(NASDAQ: TTPH) for violations of §§10(b) and 20(a) of the
Securities Exchange Act of 1934 and Rule 10b-5 promulgated
thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's shares pursuant and/or
traceable to the July 2017 Secondary Offering, or between March 8,
2017, and February 13, 2018, inclusive (the ''Class Period''), are
encouraged to contact the firm before September 25, 2018.
If you are a shareholder who suffered a loss, click here to
participate.
We also encourage you to contact Brian Schall, or Sherin
Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite
404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights
free of charge. You can also reach us through the firm's website
at www.schallfirm.com, or by email
at brian@schallfirm.com.
The class, in this case, has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
According to the Complaint, the Company made false and
misleading statements to the market. Tetraphase increased the
number of patients enrolled in the IGNITE3 trial to 1,200 from its
original 1,000 in an attempt to meet the trial’s primary endpoints.
The increase in enrolled patients indicates that the existing
enrolled population was not adequate to meet these endpoints. Based
on these facts, the Company’s public statements about business
operations and the IGNITE3 trial were false and materially
misleading throughout the class period. When the market learned the
truth about Tetraphase, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder
rights litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180813005526/en/
The Schall Law FirmBrian Schall, Esq.,Sherin Mahdavian,
Esq.,www.schallfirm.com310-301-3335info@schallfirm.com
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2024 to Jul 2024
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2023 to Jul 2024